prostate cancer precision medicine

This data describes our research into precision medicine for prostate cancer. This study employs Mendelian Randomization (MR) to investigate genetic variants as potential therapeutic targets by analyzing their relationship with prostate cancer risk.

本数据集记录了我们针对前列腺癌的精准医学研究。本研究采用孟德尔随机化（Mendelian Randomization，简称MR）方法，通过分析遗传变异与前列腺癌风险之间的关系，以探究其作为潜在治疗靶点的可能性。